Global Osteoarthritis Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
This report studies Osteoarthritis Therapeutics market, the main role of Osteoarthritis Therapeutics is to relieve pain, and cannot slow the progress of osteoarthritis.
LPI (LP Information)' newest research report, the “Osteoarthritis Therapeutics Industry Forecast” looks at past sales and reviews total world Osteoarthritis Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Therapeutics sales for 2023 through 2029. With Osteoarthritis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Osteoarthritis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Therapeutics.
The global Osteoarthritis Therapeutics market size is projected to grow from US$ 5656.5 million in 2022 to US$ 7839 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.
United States market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Osteoarthritis Therapeutics players cover Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
This report studies Osteoarthritis Therapeutics market, the main role of Osteoarthritis Therapeutics is to relieve pain, and cannot slow the progress of osteoarthritis.
LPI (LP Information)' newest research report, the “Osteoarthritis Therapeutics Industry Forecast” looks at past sales and reviews total world Osteoarthritis Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Osteoarthritis Therapeutics sales for 2023 through 2029. With Osteoarthritis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osteoarthritis Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Osteoarthritis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osteoarthritis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osteoarthritis Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osteoarthritis Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osteoarthritis Therapeutics.
The global Osteoarthritis Therapeutics market size is projected to grow from US$ 5656.5 million in 2022 to US$ 7839 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.
United States market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Osteoarthritis Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Osteoarthritis Therapeutics players cover Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Injection
- External
- Medical Care
- Personal Care
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- GlaxoSmithKline
- Bayer
- Eli Lilly
- Novartis
- Sanofi
- Horizon Pharma
- Abbott
- Mylan
- Daiichi Sankyo
- TEVA
- Almatica Pharma
- Astellas Pharma
- Tide Pharmaceutical
- Iroko Pharmaceuticals
- Hengrui Pharmaceutical
- Abiogen Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Osteoarthritis Therapeutics Market Size 2018-2029
2.1.2 Osteoarthritis Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Osteoarthritis Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Therapeutics Market Size by Type
2.3.1 Osteoarthritis Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Osteoarthritis Therapeutics Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Therapeutics Market Size by Application
2.5.1 Osteoarthritis Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
3 OSTEOARTHRITIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Osteoarthritis Therapeutics Market Size Market Share by Players
3.1.1 Global Osteoarthritis Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Osteoarthritis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Osteoarthritis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OSTEOARTHRITIS THERAPEUTICS BY REGIONS
4.1 Osteoarthritis Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.3 APAC Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.4 Europe Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Osteoarthritis Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Osteoarthritis Therapeutics Market Size by Country (2018-2023)
5.2 Americas Osteoarthritis Therapeutics Market Size by Type (2018-2023)
5.3 Americas Osteoarthritis Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoarthritis Therapeutics Market Size by Region (2018-2023)
6.2 APAC Osteoarthritis Therapeutics Market Size by Type (2018-2023)
6.3 APAC Osteoarthritis Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Osteoarthritis Therapeutics by Country (2018-2023)
7.2 Europe Osteoarthritis Therapeutics Market Size by Type (2018-2023)
7.3 Europe Osteoarthritis Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Osteoarthritis Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Osteoarthritis Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Osteoarthritis Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET FORECAST
10.1 Global Osteoarthritis Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Osteoarthritis Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Osteoarthritis Therapeutics Forecast
10.1.3 APAC Osteoarthritis Therapeutics Forecast
10.1.4 Europe Osteoarthritis Therapeutics Forecast
10.1.5 Middle East & Africa Osteoarthritis Therapeutics Forecast
10.2 Americas Osteoarthritis Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Osteoarthritis Therapeutics Market Forecast
10.2.2 Canada Osteoarthritis Therapeutics Market Forecast
10.2.3 Mexico Osteoarthritis Therapeutics Market Forecast
10.2.4 Brazil Osteoarthritis Therapeutics Market Forecast
10.3 APAC Osteoarthritis Therapeutics Forecast by Region (2024-2029)
10.3.1 China Osteoarthritis Therapeutics Market Forecast
10.3.2 Japan Osteoarthritis Therapeutics Market Forecast
10.3.3 Korea Osteoarthritis Therapeutics Market Forecast
10.3.4 Southeast Asia Osteoarthritis Therapeutics Market Forecast
10.3.5 India Osteoarthritis Therapeutics Market Forecast
10.3.6 Australia Osteoarthritis Therapeutics Market Forecast
10.4 Europe Osteoarthritis Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Osteoarthritis Therapeutics Market Forecast
10.4.2 France Osteoarthritis Therapeutics Market Forecast
10.4.3 UK Osteoarthritis Therapeutics Market Forecast
10.4.4 Italy Osteoarthritis Therapeutics Market Forecast
10.4.5 Russia Osteoarthritis Therapeutics Market Forecast
10.5 Middle East & Africa Osteoarthritis Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Osteoarthritis Therapeutics Market Forecast
10.5.2 South Africa Osteoarthritis Therapeutics Market Forecast
10.5.3 Israel Osteoarthritis Therapeutics Market Forecast
10.5.4 Turkey Osteoarthritis Therapeutics Market Forecast
10.5.5 GCC Countries Osteoarthritis Therapeutics Market Forecast
10.6 Global Osteoarthritis Therapeutics Forecast by Type (2024-2029)
10.7 Global Osteoarthritis Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Osteoarthritis Therapeutics Product Offered
11.1.3 Pfizer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Osteoarthritis Therapeutics Product Offered
11.2.3 Johnson & Johnson Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Osteoarthritis Therapeutics Product Offered
11.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Osteoarthritis Therapeutics Product Offered
11.4.3 Bayer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Osteoarthritis Therapeutics Product Offered
11.5.3 Eli Lilly Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Osteoarthritis Therapeutics Product Offered
11.6.3 Novartis Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Osteoarthritis Therapeutics Product Offered
11.7.3 Sanofi Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Osteoarthritis Therapeutics Product Offered
11.8.3 Horizon Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Osteoarthritis Therapeutics Product Offered
11.9.3 Abbott Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Osteoarthritis Therapeutics Product Offered
11.10.3 Mylan Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Osteoarthritis Therapeutics Product Offered
11.11.3 Daiichi Sankyo Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Osteoarthritis Therapeutics Product Offered
11.12.3 TEVA Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Osteoarthritis Therapeutics Product Offered
11.13.3 Almatica Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Osteoarthritis Therapeutics Product Offered
11.14.3 Astellas Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Osteoarthritis Therapeutics Product Offered
11.15.3 Tide Pharmaceutical Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Osteoarthritis Therapeutics Product Offered
11.16.3 Iroko Pharmaceuticals Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Osteoarthritis Therapeutics Product Offered
11.17.3 Hengrui Pharmaceutical Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Osteoarthritis Therapeutics Product Offered
11.18.3 Abiogen Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Osteoarthritis Therapeutics Market Size 2018-2029
2.1.2 Osteoarthritis Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Osteoarthritis Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Therapeutics Market Size by Type
2.3.1 Osteoarthritis Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Osteoarthritis Therapeutics Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Therapeutics Market Size by Application
2.5.1 Osteoarthritis Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
3 OSTEOARTHRITIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Osteoarthritis Therapeutics Market Size Market Share by Players
3.1.1 Global Osteoarthritis Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Osteoarthritis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Osteoarthritis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OSTEOARTHRITIS THERAPEUTICS BY REGIONS
4.1 Osteoarthritis Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.3 APAC Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.4 Europe Osteoarthritis Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Osteoarthritis Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Osteoarthritis Therapeutics Market Size by Country (2018-2023)
5.2 Americas Osteoarthritis Therapeutics Market Size by Type (2018-2023)
5.3 Americas Osteoarthritis Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoarthritis Therapeutics Market Size by Region (2018-2023)
6.2 APAC Osteoarthritis Therapeutics Market Size by Type (2018-2023)
6.3 APAC Osteoarthritis Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Osteoarthritis Therapeutics by Country (2018-2023)
7.2 Europe Osteoarthritis Therapeutics Market Size by Type (2018-2023)
7.3 Europe Osteoarthritis Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Osteoarthritis Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Osteoarthritis Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Osteoarthritis Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET FORECAST
10.1 Global Osteoarthritis Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Osteoarthritis Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Osteoarthritis Therapeutics Forecast
10.1.3 APAC Osteoarthritis Therapeutics Forecast
10.1.4 Europe Osteoarthritis Therapeutics Forecast
10.1.5 Middle East & Africa Osteoarthritis Therapeutics Forecast
10.2 Americas Osteoarthritis Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Osteoarthritis Therapeutics Market Forecast
10.2.2 Canada Osteoarthritis Therapeutics Market Forecast
10.2.3 Mexico Osteoarthritis Therapeutics Market Forecast
10.2.4 Brazil Osteoarthritis Therapeutics Market Forecast
10.3 APAC Osteoarthritis Therapeutics Forecast by Region (2024-2029)
10.3.1 China Osteoarthritis Therapeutics Market Forecast
10.3.2 Japan Osteoarthritis Therapeutics Market Forecast
10.3.3 Korea Osteoarthritis Therapeutics Market Forecast
10.3.4 Southeast Asia Osteoarthritis Therapeutics Market Forecast
10.3.5 India Osteoarthritis Therapeutics Market Forecast
10.3.6 Australia Osteoarthritis Therapeutics Market Forecast
10.4 Europe Osteoarthritis Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Osteoarthritis Therapeutics Market Forecast
10.4.2 France Osteoarthritis Therapeutics Market Forecast
10.4.3 UK Osteoarthritis Therapeutics Market Forecast
10.4.4 Italy Osteoarthritis Therapeutics Market Forecast
10.4.5 Russia Osteoarthritis Therapeutics Market Forecast
10.5 Middle East & Africa Osteoarthritis Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Osteoarthritis Therapeutics Market Forecast
10.5.2 South Africa Osteoarthritis Therapeutics Market Forecast
10.5.3 Israel Osteoarthritis Therapeutics Market Forecast
10.5.4 Turkey Osteoarthritis Therapeutics Market Forecast
10.5.5 GCC Countries Osteoarthritis Therapeutics Market Forecast
10.6 Global Osteoarthritis Therapeutics Forecast by Type (2024-2029)
10.7 Global Osteoarthritis Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Osteoarthritis Therapeutics Product Offered
11.1.3 Pfizer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Osteoarthritis Therapeutics Product Offered
11.2.3 Johnson & Johnson Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Osteoarthritis Therapeutics Product Offered
11.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Osteoarthritis Therapeutics Product Offered
11.4.3 Bayer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Osteoarthritis Therapeutics Product Offered
11.5.3 Eli Lilly Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Osteoarthritis Therapeutics Product Offered
11.6.3 Novartis Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Osteoarthritis Therapeutics Product Offered
11.7.3 Sanofi Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Osteoarthritis Therapeutics Product Offered
11.8.3 Horizon Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Osteoarthritis Therapeutics Product Offered
11.9.3 Abbott Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Osteoarthritis Therapeutics Product Offered
11.10.3 Mylan Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Osteoarthritis Therapeutics Product Offered
11.11.3 Daiichi Sankyo Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Osteoarthritis Therapeutics Product Offered
11.12.3 TEVA Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Osteoarthritis Therapeutics Product Offered
11.13.3 Almatica Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Osteoarthritis Therapeutics Product Offered
11.14.3 Astellas Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Osteoarthritis Therapeutics Product Offered
11.15.3 Tide Pharmaceutical Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Osteoarthritis Therapeutics Product Offered
11.16.3 Iroko Pharmaceuticals Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Osteoarthritis Therapeutics Product Offered
11.17.3 Hengrui Pharmaceutical Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Osteoarthritis Therapeutics Product Offered
11.18.3 Abiogen Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Osteoarthritis Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External
Table 5. Osteoarthritis Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Osteoarthritis Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Osteoarthritis Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Osteoarthritis Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Osteoarthritis Therapeutics Key Players Head office and Products Offered
Table 14. Osteoarthritis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Osteoarthritis Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Osteoarthritis Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Osteoarthritis Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Osteoarthritis Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Osteoarthritis Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Osteoarthritis Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Osteoarthritis Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Osteoarthritis Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Osteoarthritis Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Osteoarthritis Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Osteoarthritis Therapeutics
Table 46. Key Market Challenges & Risks of Osteoarthritis Therapeutics
Table 47. Key Industry Trends of Osteoarthritis Therapeutics
Table 48. Global Osteoarthritis Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Osteoarthritis Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Osteoarthritis Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 53. Pfizer Osteoarthritis Therapeutics Product Offered
Table 54. Pfizer Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 58. Johnson & Johnson Osteoarthritis Therapeutics Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Johnson & Johnson Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Osteoarthritis Therapeutics Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Bayer Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 68. Bayer Osteoarthritis Therapeutics Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Latest Developments
Table 72. Eli Lilly Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 73. Eli Lilly Osteoarthritis Therapeutics Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Eli Lilly Latest Developments
Table 77. Novartis Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 78. Novartis Osteoarthritis Therapeutics Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Novartis Latest Developments
Table 82. Sanofi Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 83. Sanofi Osteoarthritis Therapeutics Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Sanofi Latest Developments
Table 87. Horizon Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 88. Horizon Pharma Osteoarthritis Therapeutics Product Offered
Table 89. Horizon Pharma Main Business
Table 90. Horizon Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Horizon Pharma Latest Developments
Table 92. Abbott Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 93. Abbott Osteoarthritis Therapeutics Product Offered
Table 94. Abbott Main Business
Table 95. Abbott Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Abbott Latest Developments
Table 97. Mylan Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 98. Mylan Osteoarthritis Therapeutics Product Offered
Table 99. Mylan Main Business
Table 100. Mylan Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Mylan Latest Developments
Table 102. Daiichi Sankyo Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 103. Daiichi Sankyo Osteoarthritis Therapeutics Product Offered
Table 104. Daiichi Sankyo Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Daiichi Sankyo Main Business
Table 106. Daiichi Sankyo Latest Developments
Table 107. TEVA Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 108. TEVA Osteoarthritis Therapeutics Product Offered
Table 109. TEVA Main Business
Table 110. TEVA Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. TEVA Latest Developments
Table 112. Almatica Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 113. Almatica Pharma Osteoarthritis Therapeutics Product Offered
Table 114. Almatica Pharma Main Business
Table 115. Almatica Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Almatica Pharma Latest Developments
Table 117. Astellas Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 118. Astellas Pharma Osteoarthritis Therapeutics Product Offered
Table 119. Astellas Pharma Main Business
Table 120. Astellas Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Astellas Pharma Latest Developments
Table 122. Tide Pharmaceutical Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 123. Tide Pharmaceutical Osteoarthritis Therapeutics Product Offered
Table 124. Tide Pharmaceutical Main Business
Table 125. Tide Pharmaceutical Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Tide Pharmaceutical Latest Developments
Table 127. Iroko Pharmaceuticals Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 128. Iroko Pharmaceuticals Osteoarthritis Therapeutics Product Offered
Table 129. Iroko Pharmaceuticals Main Business
Table 130. Iroko Pharmaceuticals Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Iroko Pharmaceuticals Latest Developments
Table 132. Hengrui Pharmaceutical Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 133. Hengrui Pharmaceutical Osteoarthritis Therapeutics Product Offered
Table 134. Hengrui Pharmaceutical Main Business
Table 135. Hengrui Pharmaceutical Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Hengrui Pharmaceutical Latest Developments
Table 137. Abiogen Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 138. Abiogen Pharma Osteoarthritis Therapeutics Product Offered
Table 139. Abiogen Pharma Main Business
Table 140. Abiogen Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Abiogen Pharma Latest Developments
Table 1. Osteoarthritis Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External
Table 5. Osteoarthritis Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Osteoarthritis Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Osteoarthritis Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Osteoarthritis Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Osteoarthritis Therapeutics Key Players Head office and Products Offered
Table 14. Osteoarthritis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Osteoarthritis Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Osteoarthritis Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Osteoarthritis Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Osteoarthritis Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Osteoarthritis Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Osteoarthritis Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Osteoarthritis Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Osteoarthritis Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Osteoarthritis Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Osteoarthritis Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Osteoarthritis Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Osteoarthritis Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Osteoarthritis Therapeutics
Table 46. Key Market Challenges & Risks of Osteoarthritis Therapeutics
Table 47. Key Industry Trends of Osteoarthritis Therapeutics
Table 48. Global Osteoarthritis Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Osteoarthritis Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Osteoarthritis Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 53. Pfizer Osteoarthritis Therapeutics Product Offered
Table 54. Pfizer Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 58. Johnson & Johnson Osteoarthritis Therapeutics Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Johnson & Johnson Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 63. GlaxoSmithKline Osteoarthritis Therapeutics Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Bayer Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 68. Bayer Osteoarthritis Therapeutics Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Latest Developments
Table 72. Eli Lilly Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 73. Eli Lilly Osteoarthritis Therapeutics Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Eli Lilly Latest Developments
Table 77. Novartis Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 78. Novartis Osteoarthritis Therapeutics Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Novartis Latest Developments
Table 82. Sanofi Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 83. Sanofi Osteoarthritis Therapeutics Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Sanofi Latest Developments
Table 87. Horizon Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 88. Horizon Pharma Osteoarthritis Therapeutics Product Offered
Table 89. Horizon Pharma Main Business
Table 90. Horizon Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Horizon Pharma Latest Developments
Table 92. Abbott Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 93. Abbott Osteoarthritis Therapeutics Product Offered
Table 94. Abbott Main Business
Table 95. Abbott Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Abbott Latest Developments
Table 97. Mylan Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 98. Mylan Osteoarthritis Therapeutics Product Offered
Table 99. Mylan Main Business
Table 100. Mylan Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Mylan Latest Developments
Table 102. Daiichi Sankyo Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 103. Daiichi Sankyo Osteoarthritis Therapeutics Product Offered
Table 104. Daiichi Sankyo Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Daiichi Sankyo Main Business
Table 106. Daiichi Sankyo Latest Developments
Table 107. TEVA Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 108. TEVA Osteoarthritis Therapeutics Product Offered
Table 109. TEVA Main Business
Table 110. TEVA Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. TEVA Latest Developments
Table 112. Almatica Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 113. Almatica Pharma Osteoarthritis Therapeutics Product Offered
Table 114. Almatica Pharma Main Business
Table 115. Almatica Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Almatica Pharma Latest Developments
Table 117. Astellas Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 118. Astellas Pharma Osteoarthritis Therapeutics Product Offered
Table 119. Astellas Pharma Main Business
Table 120. Astellas Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Astellas Pharma Latest Developments
Table 122. Tide Pharmaceutical Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 123. Tide Pharmaceutical Osteoarthritis Therapeutics Product Offered
Table 124. Tide Pharmaceutical Main Business
Table 125. Tide Pharmaceutical Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Tide Pharmaceutical Latest Developments
Table 127. Iroko Pharmaceuticals Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 128. Iroko Pharmaceuticals Osteoarthritis Therapeutics Product Offered
Table 129. Iroko Pharmaceuticals Main Business
Table 130. Iroko Pharmaceuticals Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Iroko Pharmaceuticals Latest Developments
Table 132. Hengrui Pharmaceutical Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 133. Hengrui Pharmaceutical Osteoarthritis Therapeutics Product Offered
Table 134. Hengrui Pharmaceutical Main Business
Table 135. Hengrui Pharmaceutical Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Hengrui Pharmaceutical Latest Developments
Table 137. Abiogen Pharma Details, Company Type, Osteoarthritis Therapeutics Area Served and Its Competitors
Table 138. Abiogen Pharma Osteoarthritis Therapeutics Product Offered
Table 139. Abiogen Pharma Main Business
Table 140. Abiogen Pharma Osteoarthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Abiogen Pharma Latest Developments
LIST OF FIGURES
Figure 1. Osteoarthritis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Osteoarthritis Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Osteoarthritis Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Osteoarthritis Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Osteoarthritis Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Osteoarthritis Therapeutics Market Size Market Share by Type in 2022
Figure 10. Osteoarthritis Therapeutics in Medical Care
Figure 11. Global Osteoarthritis Therapeutics Market: Medical Care (2018-2023) & ($ Millions)
Figure 12. Osteoarthritis Therapeutics in Personal Care
Figure 13. Global Osteoarthritis Therapeutics Market: Personal Care (2018-2023) & ($ Millions)
Figure 14. Global Osteoarthritis Therapeutics Market Size Market Share by Application in 2022
Figure 15. Global Osteoarthritis Therapeutics Revenue Market Share by Player in 2022
Figure 16. Global Osteoarthritis Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 18. APAC Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 19. Europe Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Americas Osteoarthritis Therapeutics Value Market Share by Country in 2022
Figure 22. United States Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Osteoarthritis Therapeutics Market Size Market Share by Region in 2022
Figure 27. APAC Osteoarthritis Therapeutics Market Size Market Share by Type in 2022
Figure 28. APAC Osteoarthritis Therapeutics Market Size Market Share by Application in 2022
Figure 29. China Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Osteoarthritis Therapeutics Market Size Market Share by Country in 2022
Figure 36. Europe Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Figure 37. Europe Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Figure 38. Germany Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 52. APAC Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 53. Europe Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. United States Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Canada Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. China Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Japan Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Korea Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. India Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Australia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Germany Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. France Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. UK Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Italy Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Russia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Spain Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Israel Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Osteoarthritis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Osteoarthritis Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Osteoarthritis Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Osteoarthritis Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Osteoarthritis Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Osteoarthritis Therapeutics Market Size Market Share by Type in 2022
Figure 10. Osteoarthritis Therapeutics in Medical Care
Figure 11. Global Osteoarthritis Therapeutics Market: Medical Care (2018-2023) & ($ Millions)
Figure 12. Osteoarthritis Therapeutics in Personal Care
Figure 13. Global Osteoarthritis Therapeutics Market: Personal Care (2018-2023) & ($ Millions)
Figure 14. Global Osteoarthritis Therapeutics Market Size Market Share by Application in 2022
Figure 15. Global Osteoarthritis Therapeutics Revenue Market Share by Player in 2022
Figure 16. Global Osteoarthritis Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 18. APAC Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 19. Europe Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Osteoarthritis Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Americas Osteoarthritis Therapeutics Value Market Share by Country in 2022
Figure 22. United States Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Osteoarthritis Therapeutics Market Size Market Share by Region in 2022
Figure 27. APAC Osteoarthritis Therapeutics Market Size Market Share by Type in 2022
Figure 28. APAC Osteoarthritis Therapeutics Market Size Market Share by Application in 2022
Figure 29. China Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Osteoarthritis Therapeutics Market Size Market Share by Country in 2022
Figure 36. Europe Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Figure 37. Europe Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Figure 38. Germany Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Osteoarthritis Therapeutics Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Osteoarthritis Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 52. APAC Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 53. Europe Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. United States Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Canada Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. China Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Japan Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Korea Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. India Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Australia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Germany Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. France Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. UK Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Italy Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Russia Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Spain Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Israel Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Osteoarthritis Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Osteoarthritis Therapeutics Market Size Market Share Forecast by Application (2024-2029)
